21EGP
- Active ingredient
- metformin+pioglitazone
- Strength
- 15/500mg
- Form
- tablet
- Manufacturer
- mepaco
- Route
- oral.solid
Uses
Used with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Do not use if
Contraindicated in severe renal impairment, metabolic acidosis, and NYHA class III or IV heart failure.
Side effects
Weight gain, edema, diarrhea, nausea, and hypoglycemia with certain combinations may occur.
Warnings
Monitor for lactic acidosis, heart failure, edema, and liver dysfunction.
How it works
Combines metformin, which reduces hepatic glucose production, with pioglitazone, which improves insulin sensitivity.
Storage
Store at room temperature.